EACVI survey on the evaluation of left ventricular diastolic function.


Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
20 09 2021
Historique:
received: 13 04 2021
accepted: 21 04 2021
pubmed: 11 5 2021
medline: 21 10 2021
entrez: 10 5 2021
Statut: ppublish

Résumé

The aim of this study is to analyse how current recommendations on left ventricular (LV) diastolic function assessment have been adopted. Identifying potential discrepancies between recommendations and everyday clinical practice would enable us to better understand and address the remaining challenges in this controversial and complex field. A total of 93 centres, mainly from tertiary care settings, responded to the survey. More than three-quarters (77%) of centres follow the 2016 ASE/EACVI recommendations for LV diastolic function evaluation in patients with preserved ejection fraction based upon e', E/e', tricuspid regurgitation velocity, and left atrial (LA) volume. These recommendations were generally preferred to the previous 2009 version. Many centres also consider strain assessments in the LV (48%) and left atrium (53%) as well as diastolic stress echocardiography (33%) to be useful as additional assessments of LV diastolic function. Echocardiographic assessments of LV diastolic function were used frequently to guide therapy in 72% of centres. There is widespread adoption of current recommendation on the evaluation of LV diastolic function and these are frequently used to guide patient management. Many centres now also consider LV and LA strain assessments useful in the clinical assessment of diastolic function. These may be considered in future recommendations.

Identifiants

pubmed: 33969402
pii: 6272907
doi: 10.1093/ehjci/jeab087
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1098-1105

Subventions

Organisme : British Heart Foundation
ID : FS/14/78/31020
Pays : United Kingdom

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Auteurs

Marta Sitges (M)

Cardiovascular Institute, Hospital Clínic, Universitat de Barcelona, Villarroel 170, 08036 Barcelona, Spain.
Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
CIBERCV, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Nina Ajmone Marsan (N)

Department of Cardiology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

Matteo Cameli (M)

Department of Medical Biotechnologies, Section of Cardiology, University of Siena, Policlinico Le Scotte, 53100 Siena, Italy.

Antonello D'Andrea (A)

Department of Cardiology, Umberto I° Hospital, Viala San Francesco 84014 Nocera Inferiore (Salerno), Luigi Vanvitelli University, 81100 Caserta CE, Italy.

Ricardo Fontes Carvalho (RF)

Cardiovascular Research & Development Unit, Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.

Espen Holte (E)

Clinic of Cardiology, St. Olavs Hospital, Torgarden, 7006 Trondheim, Norway.
Department of Circulation and Medical Imaging, Norwegian University of Science and Technology NTNU, 7491 Trondheim, Norway.

Blazej Michalski (B)

Department of Cardiology, Medical University of Lodz, 91-347 Lodz, Poland.

Tomaz Podlesnikar (T)

Department of Cardiac Surgery, University Medical Centre Maribor, 2000 Maribor, Slovenia.
Department of Cardiology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.

Bogdan A Popescu (BA)

Department of Cardiology, University of Medicine and Pharmacy 'Carol Davila', Euroecolab, Emergency Institute for Cardiovascular Diseases 'Prof. Dr. C. C. Iliescu', 022328 Bucharest, Romania.

Jeanette Schulz-Menger (J)

Charité Medical Faculty of the Humboldt University Berlin, ECRC, 13125 Berlin, Germany.
DZHK, 13125 Berlin, Germany.

Ivan Stankovic (I)

Department of Cardiology, Clinical Hospital Centre Zemun, University of Belgrade, Faculty of Medicine, 11080 Belgrade, Serbia.

Kristina H Haugaa (KH)

Department of Cardiology, ProCardio Center for Innovation, Oslo University Hospital, 0424 Oslo, Norway.
Institute for Clinical Medicine, University of Oslo, Blindern, 0318 Oslo, Norway.

Marc R Dweck (MR)

BHF Centre for Cardiovascular Science, University of Edinburgh, Chancellors Building, Little France Crescent, Edinburgh EH16 4SB, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH